vs

Side-by-side financial comparison of EPR PROPERTIES (EPR) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $182.9M, roughly 1.2× EPR PROPERTIES). EPR PROPERTIES runs the higher net margin — 36.6% vs 19.4%, a 17.2% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 3.2%). EPR PROPERTIES produced more free cash flow last quarter ($269.2M vs $34.8M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 4.6%).

EPR Properties, formerly Entertainment Properties Trust, is a real estate investment trust based in Kansas City, Missouri, that invests in amusement parks, movie theaters, ski resorts, and other entertainment properties. It owns 353 properties as of 2022.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

EPR vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.2× larger
ORGO
$225.6M
$182.9M
EPR
Growing faster (revenue YoY)
ORGO
ORGO
+74.9% gap
ORGO
78.1%
3.2%
EPR
Higher net margin
EPR
EPR
17.2% more per $
EPR
36.6%
19.4%
ORGO
More free cash flow
EPR
EPR
$234.4M more FCF
EPR
$269.2M
$34.8M
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
4.6%
EPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EPR
EPR
ORGO
ORGO
Revenue
$182.9M
$225.6M
Net Profit
$66.9M
$43.7M
Gross Margin
Operating Margin
56.8%
28.1%
Net Margin
36.6%
19.4%
Revenue YoY
3.2%
78.1%
Net Profit YoY
897.0%
469.5%
EPS (diluted)
$0.80
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPR
EPR
ORGO
ORGO
Q4 25
$182.9M
$225.6M
Q3 25
$182.3M
$150.9M
Q2 25
$178.1M
$101.0M
Q1 25
$175.0M
$86.7M
Q4 24
$177.2M
$126.7M
Q3 24
$180.5M
$115.2M
Q2 24
$173.1M
$130.2M
Q1 24
$167.2M
$110.0M
Net Profit
EPR
EPR
ORGO
ORGO
Q4 25
$66.9M
$43.7M
Q3 25
$66.6M
$21.6M
Q2 25
$75.6M
$-9.4M
Q1 25
$65.8M
$-18.8M
Q4 24
$-8.4M
$7.7M
Q3 24
$46.6M
$12.3M
Q2 24
$45.1M
$-17.0M
Q1 24
$62.7M
$-2.1M
Gross Margin
EPR
EPR
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
EPR
EPR
ORGO
ORGO
Q4 25
56.8%
28.1%
Q3 25
53.5%
13.7%
Q2 25
62.5%
-12.5%
Q1 25
58.1%
-30.9%
Q4 24
25.5%
8.1%
Q3 24
51.4%
5.4%
Q2 24
45.9%
-10.7%
Q1 24
58.8%
-3.5%
Net Margin
EPR
EPR
ORGO
ORGO
Q4 25
36.6%
19.4%
Q3 25
36.5%
14.3%
Q2 25
42.5%
-9.3%
Q1 25
37.6%
-21.7%
Q4 24
-4.7%
6.1%
Q3 24
25.8%
10.7%
Q2 24
26.1%
-13.1%
Q1 24
37.5%
-1.9%
EPS (diluted)
EPR
EPR
ORGO
ORGO
Q4 25
$0.80
$0.31
Q3 25
$0.79
$0.11
Q2 25
$0.91
$-0.10
Q1 25
$0.78
$-0.17
Q4 24
$-0.19
$0.05
Q3 24
$0.53
$0.09
Q2 24
$0.51
$-0.13
Q1 24
$0.75
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPR
EPR
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$90.6M
$93.7M
Total DebtLower is stronger
$2.9B
Stockholders' EquityBook value
$2.3B
$300.1M
Total Assets
$5.7B
$598.7M
Debt / EquityLower = less leverage
1.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPR
EPR
ORGO
ORGO
Q4 25
$90.6M
$93.7M
Q3 25
$13.7M
$63.7M
Q2 25
$13.0M
$73.1M
Q1 25
$20.6M
$110.0M
Q4 24
$22.1M
$135.6M
Q3 24
$35.3M
$94.3M
Q2 24
$33.7M
$89.9M
Q1 24
$59.5M
$88.6M
Total Debt
EPR
EPR
ORGO
ORGO
Q4 25
$2.9B
Q3 25
$2.8B
Q2 25
$2.8B
Q1 25
$2.8B
Q4 24
$2.9B
Q3 24
$2.9B
$62.3M
Q2 24
$2.8B
$63.8M
Q1 24
$2.8B
$65.2M
Stockholders' Equity
EPR
EPR
ORGO
ORGO
Q4 25
$2.3B
$300.1M
Q3 25
$2.3B
$255.1M
Q2 25
$2.3B
$233.2M
Q1 25
$2.3B
$242.9M
Q4 24
$2.3B
$262.9M
Q3 24
$2.4B
$278.5M
Q2 24
$2.4B
$263.5M
Q1 24
$2.4B
$278.0M
Total Assets
EPR
EPR
ORGO
ORGO
Q4 25
$5.7B
$598.7M
Q3 25
$5.5B
$509.8M
Q2 25
$5.6B
$461.1M
Q1 25
$5.5B
$467.4M
Q4 24
$5.6B
$497.9M
Q3 24
$5.7B
$446.3M
Q2 24
$5.6B
$443.2M
Q1 24
$5.7B
$458.5M
Debt / Equity
EPR
EPR
ORGO
ORGO
Q4 25
1.26×
Q3 25
1.19×
Q2 25
1.20×
Q1 25
1.20×
Q4 24
1.23×
Q3 24
1.19×
0.22×
Q2 24
1.16×
0.24×
Q1 24
1.15×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPR
EPR
ORGO
ORGO
Operating Cash FlowLast quarter
$421.0M
$39.4M
Free Cash FlowOCF − Capex
$269.2M
$34.8M
FCF MarginFCF / Revenue
147.1%
15.4%
Capex IntensityCapex / Revenue
82.9%
2.1%
Cash ConversionOCF / Net Profit
6.29×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$568.5M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPR
EPR
ORGO
ORGO
Q4 25
$421.0M
$39.4M
Q3 25
$136.5M
$3.1M
Q2 25
$87.3M
$-32.9M
Q1 25
$99.4M
$-19.9M
Q4 24
$393.1M
$10.9M
Q3 24
$122.0M
$8.7M
Q2 24
$78.7M
$4.7M
Q1 24
$99.5M
$-10.2M
Free Cash Flow
EPR
EPR
ORGO
ORGO
Q4 25
$269.2M
$34.8M
Q3 25
$132.1M
$844.0K
Q2 25
$82.4M
$-36.5M
Q1 25
$84.7M
$-23.6M
Q4 24
$129.2M
$7.6M
Q3 24
$121.5M
$6.1M
Q2 24
$71.3M
$2.9M
Q1 24
$65.0M
$-12.4M
FCF Margin
EPR
EPR
ORGO
ORGO
Q4 25
147.1%
15.4%
Q3 25
72.5%
0.6%
Q2 25
46.3%
-36.1%
Q1 25
48.4%
-27.2%
Q4 24
72.9%
6.0%
Q3 24
67.3%
5.3%
Q2 24
41.2%
2.2%
Q1 24
38.9%
-11.3%
Capex Intensity
EPR
EPR
ORGO
ORGO
Q4 25
82.9%
2.1%
Q3 25
2.4%
1.5%
Q2 25
2.7%
3.6%
Q1 25
8.4%
4.2%
Q4 24
148.9%
2.7%
Q3 24
0.3%
2.2%
Q2 24
4.2%
1.4%
Q1 24
20.6%
2.0%
Cash Conversion
EPR
EPR
ORGO
ORGO
Q4 25
6.29×
0.90×
Q3 25
2.05×
0.14×
Q2 25
1.15×
Q1 25
1.51×
Q4 24
1.43×
Q3 24
2.62×
0.71×
Q2 24
1.74×
Q1 24
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPR
EPR

Experiential Reportable Operating Segment$173.3M95%
Education Reportable Operating Segment$9.5M5%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons